Notably, the MetaGx signature included 3 genes (DDB2, GSTZ1, and FAM1892A) that had been previously identified from the set of 12 genes sharing same-direction hazard ratios in the meta-analysis of breast and ovarian cancers (Supplementary File S6). Here, DDB2 is linked to ovarian carcinoma.